See more : Grupo International Inc. (GRPI) Income Statement Analysis – Financial Results
Complete financial analysis of Ocumetics Technology Corp. (OTC.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ocumetics Technology Corp., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Tycoons Group Enterprise Co.,Ltd. (2022.TW) Income Statement Analysis – Financial Results
- Genesis Growth Tech Acquisition Corp. (GGAA) Income Statement Analysis – Financial Results
- Schroder UK Mid Cap Fund plc (SCP.L) Income Statement Analysis – Financial Results
- USA Real Estate Holding Company (USTC) Income Statement Analysis – Financial Results
- Eco Oro Minerals Corp. (EOM.CN) Income Statement Analysis – Financial Results
Ocumetics Technology Corp. (OTC.V)
About Ocumetics Technology Corp.
Ocumetics Technology Corp., a research and product development company, designs and produces various lenses. Its products include Bionic Lens, an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. The company is headquartered in Calgary, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 117.62K | 102.21K | 96.18K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -117.62K | -102.21K | -96.18K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 907.43K | 555.70K | 235.54K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.39M | 514.68K | 99.35K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 57.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.58M | 1.45M | 514.68K | 99.35K | 35.73K | 75.96K |
| Other Expenses | 0.00 | -76.11K | -48.87K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.49M | 2.10M | 598.19K | 172.49K | 35.73K | 75.96K |
| Cost & Expenses | 3.61M | 2.10M | 598.19K | 172.49K | 35.73K | 75.96K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 29.30K | 26.63K | 25.02K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 117.62K | 102.21K | 96.18K | 73.13K | 171.86K | 0.00 |
| EBITDA | -3.50M | -2.09M | -3.42M | -99.35K | -35.73K | -75.96K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.61M | -2.22M | -598.19K | -172.49K | -35.73K | -75.96K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -37.66K | 0.00 | -1.39M | 127.65K | -2.00 | 2.00 |
| Income Before Tax | -3.64M | -2.22M | -598.19K | -172.49K | -35.73K | -75.96K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -3.64M | -49.48K | -48.87K | 1.00 | -171.86K | 0.00 |
| Net Income | -3.64M | -2.22M | -598.19K | -172.49K | -35.73K | -75.96K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.03 | -0.02 | -0.01 | -0.06 | -0.01 | -0.07 |
| EPS Diluted | -0.03 | -0.02 | -0.01 | -0.06 | -0.01 | -0.07 |
| Weighted Avg Shares Out | 115.37M | 109.72M | 103.58M | 3.00M | 3.00M | 1.14M |
| Weighted Avg Shares Out (Dil) | 115.37M | 109.72M | 103.58M | 3.00M | 3.00M | 1.14M |
Source: https://incomestatements.info
Category: Stock Reports